Trials / Unknown
UnknownNCT04157959
The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia
A Phase I, Single-Center, Open-Label Study to Evaluate Pharmacodynamics of Drug-Drug Interaction Between SHR4640 and Febuxostat in Patients With Hyperuricemia
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to assess the pharmacodynamic properties of drug-drug of SHR4640 and Febuxostat interaction in patients with Hyperuricemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR4640 dose1 | Tablet,dose1,QD |
| DRUG | Febuxostat dose2 | Tablet,dose2,QD |
Timeline
- Start date
- 2019-10-14
- Primary completion
- 2020-06-01
- Completion
- 2020-06-30
- First posted
- 2019-11-08
- Last updated
- 2019-11-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04157959. Inclusion in this directory is not an endorsement.